Roche Chairman Severin Schwan identified protectionism from the United States and China as the primary geopolitical threat to the drugmaker. Schwan delivered the warning during an event in Interlaken on June 4. Trade barriers in these two major markets impact the global operations of the Swiss pharmaceutical firm.

Geopolitical Risks Cloud Pharmaceutical Outlook